KDR and neoplasm: VEGF-A, secreted by hypoxic tumor cells, binds to tyrosine kinase vascular endothelial growth factor receptor 2 (VEGFR2) on neighboring EC, thereby activating a series of signaling pathways downstream responsible for the proliferation and migration of EC.